Simply Wall St.
How Investors Are Reacting To Eli Lilly (LLY) Building Massive Orforglipron Inventory After Strong 2025 Results
📈
AI Sentiment
Highly Positive
9/10
Eli Lilly and Company News
Latest updates and market news for LLY
20 news
Feb 10 - Feb 16, 2026
Page 1
Simply Wall St.
Eli Lilly Expands Beyond GLP-1 With RNA Cancer AI And Obesity Bets
📈
AI Sentiment
Highly Positive
9/10
Yahoo Finance Video
AI is disrupting drug discovery faster than expected
📈
AI Sentiment
Highly Positive
10/10
PR Newswire
USOPC Announces the Team USA Athlete Recovery Program in Partnership with Eli Lilly and Company
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
Lilly's Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer
📈
AI Sentiment
Highly Positive
9/10
MarketBeat
Zura Bio Highlights Key Phase 2 Tibulizumab Readouts at Guggenheim Biotech Summit 2026
📈
AI Sentiment
Highly Positive
8/10
Motley Fool
Forget AI Stocks: This Pharma Giant Is Using AI to Dominate Drug Discovery
📈
AI Sentiment
Highly Positive
8/10
Motley Fool
Eli Lilly Just Delivered Great News for Investors -- and It Goes Beyond Weight-Loss Drugs
📈
AI Sentiment
Highly Positive
9/10
Barrons.com
Beijing Could Focus on the Shopper in the Year of the Horse. Smart Ways to Play It.
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Eli Lilly Expands Beyond GLP 1s With Orna Deal And Nvidia Alliance
📈
AI Sentiment
Highly Positive
9/10
MarketBeat
Foghorn Therapeutics CEO Talks Lilly-Partnered SMARCA2 Phase 1 and New Degrader Targets at Conference
📈
AI Sentiment
Highly Positive
8/10
GuruFocus.com
Eli Lilly Builds Orforglipron Inventory Ahead of FDA Review
📈
AI Sentiment
Highly Positive
8/10
Motley Fool
Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
Eli Lilly and Company (LLY) Gets Upgraded to Buy From Hold by Freedom Capital
📈
AI Sentiment
Highly Positive
10/10
Insider Monkey
Eli Lilly (LLY) Retains Buy Rating on Strong 2026 Outlook
📈
AI Sentiment
Highly Positive
10/10
Medical Device Network
Novocure’s stock rises 37% on FDA clearance of pancreatic cancer treatment device
📈
AI Sentiment
Highly Positive
10/10
Zacks
VKTX Posts Wider-Than-Expected Loss in Q4, Stock Up on Pipeline Updates
➖
AI Sentiment
Neutral
4/10
Share this news page